Matches in SemOpenAlex for { <https://semopenalex.org/work/W2860473632> ?p ?o ?g. }
- W2860473632 endingPage "308" @default.
- W2860473632 startingPage "304" @default.
- W2860473632 abstract "Occult hepatitis B infection (OBI) may contribute to liver damage and variable therapeutic response in patients with chronic hepatitis C (CHC) infection.To study the prevalence of OBI and to evaluate its impact and/or that of anti-HBc total seropositivity on clinical outcomes and response to directly acting antiviral (DAA) therapy in CHC-infected patients.A retrospective cohort study was conducted in a tertiary care liver hospital from January to May 2017.Eighty HBsAg-negative CHC patients who were initiated on DAA therapy were retrospectively included. Archived pretreatment baseline plasma samples were retrieved and tested for quantitative HBV DNA, anti-HBs, and anti-HBc total antibodies. HCV RNA, genotype, clinical, biochemical and histopathological parameters & treatment response data were obtained from the hospital information system.Comparison of continuous variables was done by Mann-Whitney and Kruskal-Wallis tests and categorical variables by Fisher's exact test or Pearson's Chi-square test.Prevalence of OBI was 1.25%. Anti-HBc total positivity was seen in 25% patients. Based on anti-HBc total status, patients were categorized into two groups namely Group 1 (anti-HBc positive) and Group 2 (anti-HBc negative). Group 1 patients were further categorized into three subgroups based on signal/cutoff (S/Co) of HBc total antibody semi-quantitative values. HBc total antibody levels did not influence the severity of CHC disease. Comparative evaluation of parameters such as median log10 baseline RNA (P = 0.929 and 0.464), median alanine aminotransferase (ALT 0) (P = 0.519 and 0.449), ALT at 12 weeks (P = 0.875 and 0.594), sustained virological response (SVR) at 12 weeks (P = 0.405 and 0.263) and SVR at 24 weeks (P = 0.265 and 0.625) between Groups 1 and 2 and among three categories within Group 1, respectively, were not found to be statistically significant.Very low prevalence of OBI was seen in CHC patients. HBc total antibody levels did not influence clinical outcome and response to DAA therapy in this cohort." @default.
- W2860473632 created "2018-07-19" @default.
- W2860473632 creator A5016518126 @default.
- W2860473632 creator A5026415059 @default.
- W2860473632 creator A5035925055 @default.
- W2860473632 creator A5074190084 @default.
- W2860473632 creator A5076111044 @default.
- W2860473632 date "2018-07-01" @default.
- W2860473632 modified "2023-09-25" @default.
- W2860473632 title "Evaluation of impact of occult hepatitis B infection in chronic HCV-infected patients: A retrospective cohort study" @default.
- W2860473632 cites W1492085404 @default.
- W2860473632 cites W1583314880 @default.
- W2860473632 cites W184425049 @default.
- W2860473632 cites W1986904304 @default.
- W2860473632 cites W1988125082 @default.
- W2860473632 cites W1989343346 @default.
- W2860473632 cites W1989448136 @default.
- W2860473632 cites W2030155039 @default.
- W2860473632 cites W2043147492 @default.
- W2860473632 cites W2062829259 @default.
- W2860473632 cites W2063726262 @default.
- W2860473632 cites W2073899324 @default.
- W2860473632 cites W2074052657 @default.
- W2860473632 cites W2080222370 @default.
- W2860473632 cites W2101415709 @default.
- W2860473632 cites W2102184285 @default.
- W2860473632 cites W2103116252 @default.
- W2860473632 cites W2121976652 @default.
- W2860473632 cites W2125043836 @default.
- W2860473632 cites W2127509984 @default.
- W2860473632 cites W2146930525 @default.
- W2860473632 cites W2157942577 @default.
- W2860473632 cites W2165020848 @default.
- W2860473632 cites W2315619302 @default.
- W2860473632 cites W2405749651 @default.
- W2860473632 cites W2511650883 @default.
- W2860473632 cites W2566057025 @default.
- W2860473632 cites W2622076201 @default.
- W2860473632 doi "https://doi.org/10.4103/jlp.jlp_12_18" @default.
- W2860473632 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6052820" @default.
- W2860473632 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30078967" @default.
- W2860473632 hasPublicationYear "2018" @default.
- W2860473632 type Work @default.
- W2860473632 sameAs 2860473632 @default.
- W2860473632 citedByCount "5" @default.
- W2860473632 countsByYear W28604736322019 @default.
- W2860473632 countsByYear W28604736322022 @default.
- W2860473632 crossrefType "journal-article" @default.
- W2860473632 hasAuthorship W2860473632A5016518126 @default.
- W2860473632 hasAuthorship W2860473632A5026415059 @default.
- W2860473632 hasAuthorship W2860473632A5035925055 @default.
- W2860473632 hasAuthorship W2860473632A5074190084 @default.
- W2860473632 hasAuthorship W2860473632A5076111044 @default.
- W2860473632 hasBestOaLocation W28604736321 @default.
- W2860473632 hasConcept C126322002 @default.
- W2860473632 hasConcept C142724271 @default.
- W2860473632 hasConcept C159654299 @default.
- W2860473632 hasConcept C167135981 @default.
- W2860473632 hasConcept C203014093 @default.
- W2860473632 hasConcept C204787440 @default.
- W2860473632 hasConcept C2522874641 @default.
- W2860473632 hasConcept C2777410769 @default.
- W2860473632 hasConcept C2778606649 @default.
- W2860473632 hasConcept C2780593183 @default.
- W2860473632 hasConcept C520017518 @default.
- W2860473632 hasConcept C71924100 @default.
- W2860473632 hasConcept C72563966 @default.
- W2860473632 hasConcept C90924648 @default.
- W2860473632 hasConceptScore W2860473632C126322002 @default.
- W2860473632 hasConceptScore W2860473632C142724271 @default.
- W2860473632 hasConceptScore W2860473632C159654299 @default.
- W2860473632 hasConceptScore W2860473632C167135981 @default.
- W2860473632 hasConceptScore W2860473632C203014093 @default.
- W2860473632 hasConceptScore W2860473632C204787440 @default.
- W2860473632 hasConceptScore W2860473632C2522874641 @default.
- W2860473632 hasConceptScore W2860473632C2777410769 @default.
- W2860473632 hasConceptScore W2860473632C2778606649 @default.
- W2860473632 hasConceptScore W2860473632C2780593183 @default.
- W2860473632 hasConceptScore W2860473632C520017518 @default.
- W2860473632 hasConceptScore W2860473632C71924100 @default.
- W2860473632 hasConceptScore W2860473632C72563966 @default.
- W2860473632 hasConceptScore W2860473632C90924648 @default.
- W2860473632 hasIssue "03" @default.
- W2860473632 hasLocation W28604736321 @default.
- W2860473632 hasLocation W28604736322 @default.
- W2860473632 hasLocation W28604736323 @default.
- W2860473632 hasLocation W28604736324 @default.
- W2860473632 hasOpenAccess W2860473632 @default.
- W2860473632 hasPrimaryLocation W28604736321 @default.
- W2860473632 hasRelatedWork W2089121079 @default.
- W2860473632 hasRelatedWork W2089385626 @default.
- W2860473632 hasRelatedWork W2146967338 @default.
- W2860473632 hasRelatedWork W2165904982 @default.
- W2860473632 hasRelatedWork W2494047064 @default.
- W2860473632 hasRelatedWork W2603773853 @default.
- W2860473632 hasRelatedWork W3008040021 @default.
- W2860473632 hasRelatedWork W3034570849 @default.
- W2860473632 hasRelatedWork W3183348839 @default.